Literature DB >> 28387842

Association of Cholesterol Ester Transfer Protein Taq IB Polymorphism With Acute Coronary Syndrome in Egyptian National Patients.

Sahar M Abdel Maksoud1, Wael T El-Garf2, Ola S Ali3, Gamal M Shaaban4, Noha N Amer3.   

Abstract

BACKGROUND: The association between cholesterol ester transfer protein (CETP) Taq IB polymorphism and coronary artery disease (CAD) has been studied in different populations. Acute coronary syndrome (ACS) is a group of clinical symptoms within acute myocardial ischemia, including unstable angina (UA) and myocardial infarction (MI). Because there are no data reported in the literature concerning the cholesteryl ester transfer protein (CETP) Taq IB polymorphism in Egyptians, our study aimed to investigate the frequency of different CETP Taq IB genotypes in Egyptian patients with ACS and in healthy control individuals.
METHODS: The current study was conducted with 70 hospitalized patients who had been diagnosed with ACS and 30 controls. We used real-time polymerase chain reaction (RT-PCR) to determine CETP Taq IB in individuals with different genotypes.
RESULTS: The frequency of the GA genotype was significantly lower in UA patients, compared with the control group ( P  <.05).
CONCLUSIONS: The frequency of the CETP Taq IB genotypes and alleles in all groups was similar to that in other ethnic groups. Individuals with the Taq IB GA genotype may have a lower risk of UA. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  CETP; SNP; Taq IB; myocardial infarction; real-time PCR; unstable angina

Mesh:

Substances:

Year:  2017        PMID: 28387842     DOI: 10.1093/labmed/lmw071

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  1 in total

1.  Gender specific effect of CETP rs708272 polymorphism on lipid and atherogenic index of plasma levels but not on the risk of coronary artery disease: A case-control study.

Authors:  Gaojun Cai; Ganwei Shi; Zhiying Huang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.